Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H9NO3S |
| Molecular Weight | 223.248 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=CC=CC2=CC(=CC=C12)S(O)(=O)=O
InChI
InChIKey=UWPJYQYRSWYIGZ-UHFFFAOYSA-N
InChI=1S/C10H9NO3S/c11-10-3-1-2-7-6-8(15(12,13)14)4-5-9(7)10/h1-6H,11H2,(H,12,13,14)
| Molecular Formula | C10H9NO3S |
| Molecular Weight | 223.248 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Anti-angiogenic activity of heparin-like polysulfonated polymeric drugs in 3D human cell culture. | 2010-11 |
|
| Structure, morphology, and bioactivity of biocompatible systems derived from functionalized acrylic polymers based on 5-amino-2-naphthalene sulfonic acid. | 2010-07-12 |
|
| An analytical system for the characterization of highly heterogeneous mixtures of N-linked oligosaccharides. | 2009-06-01 |
|
| 5-Aminonaphthalene-1-sulfonic acid and its manganese, nickel and cobalt salts. | 2007-12 |
|
| Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice. | 2007-09 |
|
| Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate. | 2003-06-13 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:20:40 GMT 2025
by
admin
on
Mon Mar 31 21:20:40 GMT 2025
|
| Record UNII |
59G56TB11B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
59G56TB11B
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
PRIMARY | |||
|
119-79-9
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
PRIMARY | |||
|
DB08238
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
PRIMARY | |||
|
DTXSID6059497
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
PRIMARY | |||
|
4984
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
PRIMARY | |||
|
31506
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
PRIMARY | |||
|
51548-48-2
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
NON-SPECIFIC SUBSTITUTION | |||
|
m3618
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
PRIMARY | Merck Index | ||
|
204-351-2
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
PRIMARY | |||
|
44188
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
PRIMARY | |||
|
8408
Created by
admin on Mon Mar 31 21:20:40 GMT 2025 , Edited by admin on Mon Mar 31 21:20:40 GMT 2025
|
PRIMARY |